Related Experiment Video
Updated: Jun 2, 2026
07:36
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Maternal preeclampsia and neonatal outcomes.
Carl H Backes1, Kara Markham, Pamela Moorehead
1Department of Pediatrics, College of Medicine, The Ohio State University and Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH 43205, USA.
Journal of Pregnancy
|May 7, 2011
Summary
Preeclampsia management requires careful consideration. Delivery can benefit mothers but poses risks to late-preterm infants, necessitating optimized fetal outcome strategies.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Neonatology
Background:
- Preeclampsia is a complex pregnancy disorder with significant maternal and neonatal risks.
- Current clinical guidelines for preeclampsia management are incomplete, impacting physician decision-making.
- Premature delivery, while sometimes necessary for preeclampsia, adversely affects neonatal outcomes, especially for late-preterm infants.
Purpose of the Study:
- To review current literature on preeclampsia diagnosis and obstetrical management.
- To examine the outcomes of late-preterm infants born to mothers with preeclampsia.
- To identify strategies for optimizing fetal outcomes in preeclampsia pregnancies.
Main Methods:
- Literature review of studies on preeclampsia diagnosis and management.
- Analysis of neonatal outcomes, focusing on late-preterm infants.
- Synthesis of current data to inform clinical practice.
Main Results:
- Preeclampsia management involves balancing maternal benefits of delivery against neonatal risks.
- Late-preterm infants represent a significant proportion of preterm births and face substantial morbidity.
- Optimizing fetal outcomes requires a comprehensive approach considering both maternal and neonatal factors.
Conclusions:
- Effective preeclampsia care necessitates improved clinical decision-making tools.
- Addressing the risks to late-preterm infants is crucial in managing preeclampsia.
- Further research is needed to refine strategies for optimizing fetal well-being in pregnancies complicated by preeclampsia.
Related Concept Videos
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...